Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02415647 · ClinicalTrials.gov registry record
Longitudinal Family/Molecular Genetic Study to Validate Research Domain Criteria
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 2,806
- Enrollment target
NCT02415647: Completed study, sponsored by State University of New York - Upstate Medical University.
NCT02415647 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 2,806 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02415647 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 2,806 participants
- Enrollment target
Study Summary
The purpose of this research is to study new ways of classifying mental disorders in children based on observable behavior and genetics to ultimately diagnose these disorders better.
Primary Outcome
Measures: Self-report, computerized tests, and DNA samples; Assessing correlations among family members and predictors of psychopathology.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,806 participants |
| Start Date | 2014-10 |
| Est. Completion | 2020-05-31 |
What the finished NCT02415647 record still lists
NCT02415647 is an observational study that tracks outcomes without assigning an intervention. Its 2,806 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02415647 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02415647 about?
NCT02415647 is a clinical study titled "Longitudinal Family/Molecular Genetic Study to Validate Research Domain Criteria". The purpose of this research is to study new ways of classifying mental disorders in children based on observable behavior and genetics to ultimately diagnose these disorders better.
What is the current status of trial NCT02415647?
This trial is currently completed. The enrollment target is 2,806 participants. The study started on 2014-10. Estimated completion is 2020-05-31.
Who is sponsoring clinical trial NCT02415647?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05932602 · 2,812 participants
AVEIR DR Coverage With Evidence Development (CED) Study
- NCT05443737 · 2,800 participants · Phase 3
Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients
- NCT05899439 · 2,800 participants
Immune Function and the Progression to T1D
- NCT06089109 · 2,800 participants · NA
Creating VIP Corps to Reduce Maternal Deaths
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia